(Q35541039)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25576297%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

title

Sodium valproate ameliorates diabetes-induced fibrosis and renal damage by the inhibition of histone deacetylases in diabetic rat (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25576297%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25576297%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Kulhushan Tikoo

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25576297%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

author name string

Gopabandhu Jena

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25576297%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

publication date

7 January 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25576297%20AND%20SRC:MED&resulttype=core&format=json

Experimental and Molecular Pathology

27 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25576297%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

volume

98

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25576297%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25576297%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

page(s)

230-239

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25576297%20AND%20SRC:MED&resulttype=core&format=json

Valproate ameliorates thioacetamide-induced fibrosis by hepatic stellate cell inactivation.

27 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.01.003

Pretreatment with valproic acid, a histone deacetylase inhibitor, enhances the sensitivity of the peripheral blood micronucleus assay in rodents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.01.003

Largazole, a class I histone deacetylase inhibitor, enhances TNF-α-induced ICAM-1 and VCAM-1 expression in rheumatoid arthritis synovial fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.01.003

Fibrosis in diabetes complications: Pathogenic mechanisms and circulating and urinary markers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.01.003

Bone marrow-derived myofibroblasts contribute to the renal interstitial myofibroblast population and produce procollagen I after ischemia/reperfusion in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.01.003

Histone deacetylase inhibitors: mechanisms of cell death and promise in combination cancer therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.01.003

Transforming growth factor β1 (TGF-β1) enhances expression of profibrotic genes through a novel signaling cascade and microRNAs in renal mesangial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.01.003

Molecular and therapeutic potential and toxicity of valproic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.01.003

Valproic acid exhibits biphasic effects on apoptotic cell death of activated lymphocytes through differential modulation of multiple signaling pathways.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.01.003

The origin of renal fibroblasts and progression of kidney disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.01.003

Epithelial-mesenchymal transition in renal fibrosis - evidence for and against.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.01.003

Histone deacetylase inhibition attenuates diabetes-associated kidney growth: potential role for epigenetic modification of the epidermal growth factor receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.01.003

Histone deacetylase 4 is required for TGFbeta1-induced myofibroblastic differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.01.003

Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.01.003

Valproic acid prevents penile fibrosis and erectile dysfunction in cavernous nerve-injured rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.01.003

Epigenetic Regulation of Tumor Endothelial Cell Anergy: Silencing of Intercellular Adhesion Molecule-1 by Histone Modifications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.01.003

Histone deacetylase 7, a potential target for the antifibrotic treatment of systemic sclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.01.003

The myofibroblast: one function, multiple origins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.01.003

Recent developments in myofibroblast biology: paradigms for connective tissue remodeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.01.003

Trichostatin A prevents the accumulation of extracellular matrix in a mouse model of bleomycin-induced skin fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.01.003

Diabetic nephropathy--emerging epigenetic mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.01.003

Sodium butyrate, a HDAC inhibitor ameliorates eNOS, iNOS and TGF-β1-induced fibrogenesis, apoptosis and DNA damage in the kidney of juvenile diabetic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.01.003

Protective role of sodium butyrate, a HDAC inhibitor on beta-cell proliferation, function and glucose homeostasis through modulation of p38/ERK MAPK and apoptotic pathways: study in juvenile diabetic rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.01.003

Investigation on sodium valproate induced germ cell damage, oxidative stress and genotoxicity in male Swiss mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.01.003

Valproate attenuates the proteinuria, podocyte and renal injury by facilitating autophagy and inactivation of NF-κB/iNOS signaling in diabetic rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.01.003

Mechanisms involved in the pathogenesis of tubulointerstitial fibrosis in 5/6-nephrectomized rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.01.003

Inhibition of p38 mitogen-activated protein kinase and transforming growth factor-beta1/Smad signaling pathways modulates the development of fibrosis in adriamycin-induced nephropathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.01.003

Blocking the class I histone deacetylase ameliorates renal fibrosis and inhibits renal fibroblast activation via modulating TGF-beta and EGFR signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.01.003

Chronic administration of valproic acid inhibits activation of mouse hepatic stellate cells in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.01.003

Gene expression profiling after treatment with the histone deacetylase inhibitor trichostatin A reveals altered expression of both pro- and anti-apoptotic genes in pancreatic adenocarcinoma cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.01.003

Histone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-beta1-induced renal injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.01.003

CCN3/CCN2 regulation and the fibrosis of diabetic renal disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.01.003

Histone deacetylase inhibition promotes fibroblast apoptosis and ameliorates pulmonary fibrosis in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.01.003

Interaction between macrophages, TGF-beta1, and the COX-2 pathway during the inflammatory phase of skeletal muscle healing after injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.01.003

Pathologic classification of diabetic nephropathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.01.003

Valproic acid attenuates proteinuria and kidney injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.01.003

HDAC inhibitors in experimental liver and kidney fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.01.003

The role of epigenetics in the pathology of diabetic complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.01.003

Histone deacetylases and their inhibitors: molecular mechanisms and therapeutic implications in diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.01.003

Histone deacetylase 4 selectively contributes to podocyte injury in diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.01.003

Influence of 3-aminobenzamide, an inhibitor of poly(ADP-ribose)polymerase, in the evaluation of the genotoxicity of doxorubicin, cyclophosphamide and zidovudine in female mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.01.003

Inhibition of histone deacetylase activity suppresses epithelial-to-mesenchymal transition induced by TGF-beta1 in human renal epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.01.003

Involvement of p300/CBP and epigenetic histone acetylation in TGF-β1-mediated gene transcription in mesangial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.01.003

Valproic acid attenuates inflammation in experimental autoimmune neuritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.01.003

10.1016/J.YEXMP.2015.01.003

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25576297%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

1 reference